ArticleMedicine2026
Ischemic heart disease and cerebral infarction associated mortality in the United States: A nationwide retrospective analysis of death certificate data from 1999 to 2023.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic Heart Disease (IHD) and cerebral infarction share risk factors and are leading cardiovascular causes of death. We analyzed national mortality trends and disparities for co-occurring IHD and cerebral infarction in older United States adults. Using the CDC WONDER database, we analyzed 1999 to 2023 death records for adults aged ≥55 listing both conditions as underlying or contributing causes. Age-adjusted mortality rates (AAMRs) per 1,00,000 and annual percent changes (APCs) were calculated via Joinpoint regression. Of 1,06,423 deaths, the overall AAMR declined from 1999 to 2011 (APC: -11.42), then rose sharply through 2023 (APC: 9.64). Females comprised 50.20% of absolute deaths, but males had a higher 2023 AAMR (7.2 vs 4.9). Non-Hispanic African Americans had the highest AAMR (6.5). The West (6.0) and nonmetropolitan areas (6.0) faced the heaviest mortality burdens. Following a decade of decline, mortality for comorbid IHD and cerebral infarction increased significantly after 2011. Disparities among males, Non-Hispanic African Americans, and rural populations underscore the need for targeted healthcare interventions and equitable resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.